三家生物制药公司根据Nasdaq规则授予新雇员股票,允许未经股东批准股权。 Three biopharma firms granted stock awards to new hires under Nasdaq rule allowing equity without shareholder approval.

三个生物制药公司——Olema Occology公司、Akebia治疗公司和NewAmsterdam Pharma公司——根据Nasdaq Listing规则第5635(c)(4)条,宣布向新雇员发放股票奖励,该规则允许公司在未经股东批准的情况下向新雇员提供股权奖励,这通常与初始就业有关。 Three biopharmaceutical companies—Olema Oncology, Akebia Therapeutics, and NewAmsterdam Pharma—announced inducement grants of stock awards to new employees, complying with Nasdaq Listing Rule 5635(c)(4), which allows companies to grant equity incentives to new hires without shareholder approval, typically in connection with initial employment. 赠款的具体条款没有披露。 The specific terms of the grants were not disclosed.